nach oben

Social Psychiatry and Psychiatric Epidemiology

Erschienen in:

01.11.2014 | Original Paper

Predictors of prescribed medication use for depression, anxiety, stress, and sleep problems in mid-aged Australian women

verfasst von: Margot J. Schofield, Asaduzzaman Khan

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

The study examined prevalence of self-reported use of medication recommended or prescribed by a doctor for depression, anxiety, stress, and sleep problems; and modelled baseline factors that predicted use over 3 years for each condition.

Methods

Analyses were undertaken on the 2001 and 2004 surveys of mid-aged women in the Australian Longitudinal Study on Women’s Health. Dependent variables were self-reported use in past 4 weeks of medications recommended or prescribed by a doctor for depression, anxiety, stress, or sleep problems in 2001 and 2004. Generalized Estimating Equations (GEE) were used to predict medication use for each condition over 3 years.

Results

Prevalence of prescribed medication use (2001, 2004) for each condition was depression (7.2, 8.9 %), anxiety (7.4, 9.0 %), stress (4.8, 5.7 %), and sleep problems (8.7, 9.5 %). Multivariable analyses revealed that odds of medication use across 3 years in all four conditions were higher for women with poorer mental and physical health, using hormone replacement therapy (HRT), or having seen a counsellor; and increased over time for depression, anxiety, and stress models. Medication use for depression was also higher for overweight/obese women, ex-smokers, and unmarried. Medication use for anxiety was higher for unmarried and non-working/low occupational women. Medication use for stress was higher for non-working women. Additional predictors of medication for sleep were surgical menopause, and area of residence.

Conclusions

Self-reported use of prescribed medication for four mental health conditions is increased over time after controlling for mental and physical health and other variables. Research needs to explore decision-making processes influencing differential rates of psychoactive medication use and their relationship with health outcomes.

Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A (2007) The burden of disease and injury in Australia 2003. AIHW cat no. PHE 82. AIHW, Canberra

Slade T, Johnston A, Oakley Browne MA, Andrews G, Whiteford H (2009) 2007 National Survey of Mental Health and Wellbeing: methods and key findings. Aust N Z J Psychiatry 43(7):594–605PubMedCrossRef

Britt H, Miller GC, Charles J, et al. (2011) General Practice Activity in Australia 2010–11: BEACH, Bettering the Evaluation And Care of Health. General practice series, no. 29. Sydney University Press, Sydney

Burgess PM, Pirkis JE, Slade TN, Johnston AK, Meadows GN, Gunn JM (2009) Service use for mental health problems: findings from the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 43:606–614CrossRef

Department of Health and Ageing (2011) Australian statistics on medicines 2009. Commonwealth of Australia, Canberra

Atlantis E, Sullivan T, Sartorius N, Almeida OP (2012) Changes in the prevalence of psychological distress and use of antidepressants or anti-anxiety medications associated with comorbid chronic diseases in the adult Australian population, 2001–2008. Aust N Z J Psychiatry 46(5):445–456PubMedCrossRef

Boyce P, Malhi G (2012) Supping with the devil? The dangers of liaisons between pharma and our profession. Aust N Z J Psychiatry 46:493–494PubMedCrossRef

Partridge B, Lucke J, Hall W (2012) Public attitudes towards the acceptability of using drugs to treat depression and ADHD. Aust N Z J Psychiatry 46:958–965PubMedCrossRef

Ilyas S, Moncrieff J (2012) Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010. Br J Psychiatry 200:393–398PubMedCrossRef

10.

Mojtabai R (2008) Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychother Psychosom 77:83–92. doi:10.1159/000112885 PubMedCrossRef

11.

Stephenson CP, Karanges E, McGregor IS (2013) Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Aust N Z J Psychiatry 47:74–87. doi:10.1177/0004867412466595 PubMedCrossRef

12.

Parikh SV, Lesage AD, Kennedy SH, Goering PN (1999) Depression in Ontario: under-treatment and factors related to antidepressant use. J Affect Disord 52:67–76PubMedCrossRef

13.

Harris MG, Burgess PM, Pirkis J, Siskind A, Slade T, Whiteford HA (2011) Correlates of antidepressant and anxiolytic, hypnotic or sedative medication use in an Australian community sample. Aust N Z J Psychiatry 45:249–260PubMedCrossRef

14.

Hollingworth SA, Burgess PM, Whiteford HA (2010) Affective and anxiety disorders: prevalence, treatment and antidepressant medication use. Aust N Z J Psychiatry 44:513–519. doi:10.3109/00048670903555138 PubMedCrossRef

15.

Lader M (2011) Benzodiazepines revisited—will we ever learn? Addiction 106:2086–2109. doi:10.1111/j.1360-0443.2011.03563.x PubMedCrossRef

16.

Hollingworth SA, Siskind DJ (2010) Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiol Drug Saf 19:280–288. doi:10.1002/pds.1899 PubMedCrossRef

17.

Goldney R, Bain M (2006) Prevalence of psychotropic use in a South Australian population. Aust Psychiatry 14:379–383CrossRef

18.

Page AN, Swannell S, Martin G, Hollingworth S, Hickie IB, Hall WD (2009) Sociodemographic correlates of antidepressant utilisation in Australia. Med J Aust 190:479–483PubMed

19.

Kim J, Dennerstein L, Guthrie J (2006) Mental health treatments and associated factors amongst mid-aged Melbourne women. Archives Women’s Ment Health 9:15–22CrossRef

20.

Bramesfeld A, Grobe T, Schwartz F (2007) Who is treated, and how, for depression? An analysis of statutory health insurance data in Germany. Soc Psychiatry Psychiatr Epidemiol 42:740–746. doi:10.1007/s00127-007-0225-9 PubMedCrossRef

21.

Chien I-C, Bih S-H, Lin C-H, Chou Y-J, Lee W-G, Lee C-H, Chou P (2011) Correlates and psychiatric disorders associated with psychotropic drug use in Taiwan. Soc Psychiatry Psychiatr Epidemiol 46:77–84. doi:10.1007/s00127-009-0169-3 PubMedCrossRef

22.

Oksanen T, Vahtera J, Wesyerlund H, Pentti J, Sjösten N, Virtanen M, Kawachi I, Kivimäki M (2011) Is retirement beneficial for mental health? Antidepressant use before and after retirement. Epidemiology 22:553–559. doi:10.1097/EDE.0b013e31821c41bd PubMedCrossRefPubMedCentral

23.

Weisberg RB, Dyck I, Culpepper L, Keller MB (2007) Psychiatric treatment in primary care patients with anxiety disorders: a comparison of care received from primary care providers and psychiatrists. Am J Psychiatry 164:276–282PubMedCrossRef

24.

Alonso J, Angermeyer MC, Bernert S et al (2004) Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 109(Suppl 420):55–64

25.

Comeau J, Davies L (2012) Patterns of depressive symptoms and antidepressant use among women survivors of intimate partner violence. Soc Psychiatry Psychiatr Epidemiol 47:1527–1537. doi:10.1007/s00127-011-0459-4 PubMedCrossRef

26.

Demyttenaere K, Bonnewyn A, Bruffaerts R, De Girolamo G, Gasquet I, Kovess V, Haro JM, Alonso J (2008) Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD). J Affect Disord 110:84–93. doi:10.1016/j.jad.2008.01.011 PubMedCrossRef

27.

Tómasson K, Tómasson H, Zoёga T, Zigfússon E, Helgason T (2007) Epidemiology of psychotropic medication use: comparison of sales, prescriptions and survey data in Iceland. Nord J Psychiatry 61:471–478. doi:10.1080/08039480701773311 PubMedCrossRef

28.

Parslow RA, Jorm AF (2001) Predictors of types of help provided to people using services for mental health problems: an analysis of the Australian National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 35(2):183–189PubMedCrossRef

29.

Stein MB, Barrett-Connor E (2002) Quality of life in older adults receiving medications for anxiety, depression or insomnia: findings from a community-based study. Am J Geriatr Psychiatry 10:568–574PubMedCrossRef

30.

Voyer P, Cohen D, Lauzon S, Collin J (2004) Factors associated with psychotropic drug use among community-dwelling older persons: a review of empirical studies. BMC Nurs 3:3. doi:10.1186/1472-6955-3-3 PubMedCrossRefPubMedCentral

31.

Freeman EW, Sammel MD, Boorman DW, Zhang R (2014) Longitudinal pattern of depressive symptoms around natural menopause. JAMA Psychiatry 71(1):36–43. doi:10.1001/jamapsychiatry.2013.2819 PubMedCrossRef

32.

Hardy R, Kuh D (2002) Change in psychological and vasomotor symptom reporting during the menopause. Soc Sci Med 55:1975–1988PubMedCrossRef

33.

Graziottin A, Serafini A (2009) Depression and the menopause: why antidepressants are not enough? Menopause 15(2):76–81. doi:10.1258/mi.2009.009021 CrossRef

34.

Beck CA, Williams JVA, Wang JL, Kassam A, El-Guebaly N, Currie S et al (2005) Psychotropic medication use in Canada. Can J Psychiatry 50:605–613PubMed

35.

Rutledge T, Linke S, Krantz D, Johnson B, Bittner V, Eastwood J, Eteiba W, Pepine C, Vaccarino V, Francis J, Vido D, Merz CNB (2009) Cormorbid depression and anxiety symptoms as predictors of cardiovasculat events: results from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study. Psychosom Med 71:958–964PubMedCrossRefPubMedCentral

36.

Patten SB, Esposito E, Carter B (2007) Reasons for antidepressant prescriptions in Canada. Pharmacoepidemiol Drug Saf 16:746–752PubMedCrossRef

37.

Brown W, Bryson L, Byles J, Dobson A, Lee C, Mishra G, Schofield M (1998) Women’s Health Australia: recruitment for a national longitudinal cohort study. Women Health 28:23–40PubMedCrossRef

38.

Young AF, Powers JR, Bell SL (2006) Attrition in longitudinal studies: who do you lose? Aust N Z J Public Health 30:353–361PubMedCrossRef

39.

Lee C, Dobson AJ, Brown WJ, Bryson L, Byles JE, Warner-Smith P, Young AF (2005) Cohort profile: the Australian Longitudinal Study on Women’s Health. Int J Epidemiol 34:987–991PubMedCrossRef

40.

Andresen EM, Malmgren JA, Carter WB, Patrick DL (1994) Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 10:77–84PubMed

41.

Ware JE, Kosinski M, Keller SD (1994) SF-36 SF-36 physical and mental health summary scales: a user’s manual. The Health Institute, New England Medical Center, Boston, MA

42.

Mishra G, Schofield MJ (1998) Norms for the Physical and Mental Component Summary scores of the SF-36 for young, middle and older Australian women. Qual Life Res 7:215–220PubMedCrossRef

43.

Bell S, Lee C (2002) Development of the Perceived Stress Questionnaire for Young Women. Psychol Health Med 7(2):189–201CrossRef

44.

Bell S, Lee C (2003) Perceived stress revisited: the Women’s Health Australia project Young cohort. Psychol Health Med 8(3):343–353CrossRef

45.

Sherbourne CD, Stewart AL (1991) The MOS Social Support Survey. Soc Sci Med 32(6):705–714PubMedCrossRef

46.

Moser A, Stuck AE, Silliman RA, Ganz PA, Clough-Gorr KM (2012) The eight-item modified Medical Outcomes Study Social Support Survey: psychometric evaluation showed excellent performance. J Clin Epidemiol 65(10):1107–1116PubMedCrossRefPubMedCentral

47.

Medical Outcomes Study Social Support Index (2002) University of Newcastle. http://www.alswh.org.au/for-researchers/data/data-dictionary-supplement. Accessed 4 June 2014

48.

Zeger S, Liang K (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121–130PubMedCrossRef

49.

Horton N, Bebchuk J, Jones C, Lipsitz S, Catalano P, Zahner G, Fitzmaurice G (1999) Goodness-of-fit for GEE: an example with mental health service utilization. Stat Med 18:213–222PubMedCrossRef

50.

Zhang J, Yu K (1998) What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280:1690–1691PubMedCrossRef

51.

Parslow RA, Jorm AF (2004) Use of prescription medications and complementary and alternative medicines to treat depressive and anxiety symptoms: results from a community sample. J Affect Disord 82:77–84PubMedCrossRef

52.

Rauma PH, Koivumaa-Honkanen H, Kröger H, Tuppurainen MT, Kauhanen J, Honkanen RJ (2013) The relationship between self-reported and registry-based data on use of psychoactive medications in postmenopausal women. BMC Psychiatry 13:180. doi:10.1186/1471-244X-13-180 PubMedCrossRefPubMedCentral

53.

Pampallona S, Bollini P, Tibalidi G, Kupelnick B, Munizza C (2004) Combined pharmacotherapy and psychological treatment for depression. A systematic review. Arch Gen Psychiatry 61:714–719PubMedCrossRef

54.

Whiteford H, Doessel D, Sheridan J (2008) Uptake of Medicare Benefits Schedule items by psychologists and other mental health practitioners. Clin Psychol 12:50–56CrossRef

Titel: Predictors of prescribed medication use for depression, anxiety, stress, and sleep problems in mid-aged Australian women
verfasst von: Margot J. Schofield
Asaduzzaman Khan
Publikationsdatum: 01.11.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Social Psychiatry and Psychiatric Epidemiology / Ausgabe 11/2014
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI: https://doi.org/10.1007/s00127-014-0896-y

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Objective

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2014

The impact of immigration and visible minority status on psychosis symptom profile

Physical activity patterns and risk of depression in young adulthood: a 20-year cohort study since childhood

Childhood maltreatment, adult attachment and psychotic symptomatology: a study in patients, siblings and controls

The influence of different types of war experiences on depression and anxiety in a Ugandan cohort of war-affected youth: the WAYS study